132 related articles for article (PubMed ID: 6091149)
21. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
22. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
23. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
[TBL] [Abstract][Full Text] [Related]
24. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
25. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
26. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
27. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.
Fidler IJ; Nicolson GL
J Natl Cancer Inst; 1976 Nov; 57(5):1199-202. PubMed ID: 1003551
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor effects of radiolabeled syngeneic monoclonal anti-melanoma antibodies.
Wakabayashi S; Okamoto S; Taniguchi M
Gan; 1984 Aug; 75(8):707-13. PubMed ID: 6489678
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies.
Johnson CW; Barth RF; Adams D; Holman B; Price JE; Sautins I
Cancer Res; 1987 Feb; 47(4):1111-7. PubMed ID: 2433032
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodies.
Gomibuchi M; Saxton RE; Lake RR; Katano M; Irie RF
Int J Rad Appl Instrum B; 1986; 13(1):13-9. PubMed ID: 3771234
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
[TBL] [Abstract][Full Text] [Related]
32. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
33. Localization of human colorectal tumor xenografts in the nude mouse with the use of radiolabeled monoclonal antibody.
Zalcberg JR; Thompson CH; Lichtenstein M; Andrews J; McKenzie IF
J Natl Cancer Inst; 1983 Oct; 71(4):801-8. PubMed ID: 6578372
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.
Osaka G; Carey K; Cuthbertson A; Godowski P; Patapoff T; Ryan A; Gadek T; Mordenti J
J Pharm Sci; 1996 Jun; 85(6):612-8. PubMed ID: 8773958
[TBL] [Abstract][Full Text] [Related]
35. [Biodistribution of 99mTC-HMPAO in healthy rats and B16 melanoma carriers].
Calderón CF; Collazo A; Cepero W; Rodríguez JC; Montalvo M; Robustillo M; Avila A; Pérez RM
Rev Esp Med Nucl; 1999 Dec; 18(6):425-30. PubMed ID: 10611568
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and preparation of technetium-99m-labeled D-D₃ monoclonal antibody against pro-gastrin-releasing peptide (₃₁₋₉₈) in mice.
Hao LJ; Hong ZH; Shi YZ; Liu ZL; Zhou XL
Chin Med J (Engl); 2013 Apr; 126(7):1333-6. PubMed ID: 23557567
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
Brekken C; Hjelstuen MH; Bruland ØS; de Lange Davies C
Anticancer Res; 2000; 20(5B):3513-9. PubMed ID: 11131655
[TBL] [Abstract][Full Text] [Related]
39. [99mTc(CO)3]+ and [99mTcO2]+ radiolabeled cyclic melanotropin peptides for melanoma SPECT imaging.
Zhang X; Teixeira V; Porcal W; Cabral P; Gambini JP; Fernandez M; Gallazzi F; Quinn TP
Curr Radiopharm; 2014; 7(1):63-74. PubMed ID: 25022516
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice.
Douillard JY; Chatal JF; Saccavini JC; Curtet C; Kremer M; Peuvrel P; Koprowski H
Eur J Nucl Med; 1985; 11(4):107-13. PubMed ID: 4054153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
